Form D · Biotechnology
EFFECTOR THERAPEUTICS, INC.
San Diego, CA · CIK 0001577561
Offering snapshot reported May 14, 2019 · SEC filing
- Reported sold
- $20.4M Offering amount: $21.8M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2019 | Initial | $20,422,514 | No comparison | 25 | SEC filing |
| Jul 27, 2017 | Initial | $16,800,008 | No comparison | 26 | SEC filing |
| Feb 22, 2016 | Amendment | $56,000,005 | $16,000,001vs Dec 23, 2015 | 20 | SEC filing |
| Dec 23, 2015 | Initial | $40,000,004 | No comparison | 17 | SEC filing |
| Jul 24, 2015 | Amendment | $36,206,089 | $18,847,222vs May 28, 2013 | 15 | SEC filing |
| Aug 14, 2014 | Amendment | $21,539,423 | $4,180,556vs May 28, 2013 | 15 | SEC filing |
| May 28, 2013 | Initial | $17,358,867 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-339536
For Series C, Preferred Stock.
Source: Form D, filed May 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeremy Barton, M.D. | Executive |
| Carol G. Gallagher, Pharm.D. | Director |
| Simeon George | Director |
| Simeon J. George, M.D. | Director |
| Markus Goebel | Director |
| Markus Goebel, M.D., Ph.D. | Director |
| Ken Haas | Director |
| Kenneth Haas, J.D. | Director |
| Elaine Jones, Ph.D. | Director |
| Maha Katabi | Director |
| Maha Katabi, Ph.D. | Director |
| Stefan Larson, Ph.D. | Director |
| Laurence Lasky | Director |
| Laurence Lasky, Ph.D. | Director |
| David Maki | Director |
| David Maki, J.D. | Director |
| Alana Mc Nulty | Executive |
| Denis Patrick, Ph.D. | Director |
| Jonathan Root | Director |
| Jonathan D. Root, M.D. | Director |
| John W. Smither | Director |
| Stephen T. Worland, Ph.D. | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11180 Roselle Street
San Diego, CA, 92121
San Diego, CA, 92121